Conard Wai's most recent trade in Clover Health Investments Corp - Ordinary Shares - Class A was a trade of 24,215 Class A Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 15 Jul 2026 | 24,215 | 1,145,699 | - | 4.7 | 113,084 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 3.99 per share. | 28 May 2026 | 220,426 | 1,390,056 | - | 4.0 | 879,500 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.04 per share. | 15 Apr 2026 | 23,463 | 1,169,914 | - | 2.0 | 47,865 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 267,766 | 1,193,377 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 14 Mar 2026 | 100,195 | 925,611 | - | 2.0 | 198,386 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.81 per share. | 15 Jan 2026 | 25,868 | 1,025,806 | - | 2.8 | 72,689 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 14 Dec 2025 | 98,411 | 1,051,674 | - | 2.7 | 265,710 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 96,448 | 1,178,015 | - | 3.5 | 340,461 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 27,930 | 1,150,085 | - | 3.5 | 98,593 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 92,181 | 1,274,463 | - | 2.8 | 258,107 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.06 per share. | 14 Sep 2025 | 98,412 | 1,573,425 | - | 3.1 | 301,141 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 31 Jul 2025 | 27,930 | 1,671,837 | - | 2.9 | 80,718 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 3.29 per share. | 22 Jul 2025 | 118,600 | 1,494,898 | - | 3.3 | 390,194 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 3.32 per share. | 22 Jul 2025 | 91,197 | 1,403,701 | - | 3.3 | 302,774 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 14 Jun 2025 | 98,411 | 3,138,535 | - | 2.9 | 284,408 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 30 Apr 2025 | 26,593 | 3,236,946 | - | 3.4 | 90,416 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.66 per share. | 14 Mar 2025 | 80,524 | 3,263,539 | - | 3.7 | 294,718 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.39 per share. | 31 Jan 2025 | 24,470 | 3,344,063 | - | 4.4 | 107,423 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.11 per share. | 14 Dec 2024 | 98,217 | 3,368,533 | - | 3.1 | 305,455 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.12 per share. | 31 Oct 2024 | 111,496 | 3,466,750 | - | 4.1 | 459,364 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 726,114 | 3,578,246 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 379,866 | 1,699,767 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 189,934 | 3,043,529 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 98,217 | 2,852,132 | - | 3.0 | 293,669 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 93,180 | 2,950,349 | - | 3.0 | 278,608 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 13 Sep 2024 | 15,203 | 1,613,498 | - | 3.3 | 49,562 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 14 Jun 2024 | 69,148 | 2,853,595 | - | 1.1 | 75,371 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.73 per share. | 14 Mar 2024 | 74,396 | 2,922,743 | - | 0.7 | 54,309 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Wai Conard | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 14 Dec 2023 | 96,086 | 2,997,139 | - | 1 | 96,086 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 14 Jun 2023 | 86,763 | 2,749,311 | - | 0.9 | 81,557 | Class A Common Stock |